SG11201700530PA - Agent for improving brain function and agent for preventing or treating cognitive impairment - Google Patents

Agent for improving brain function and agent for preventing or treating cognitive impairment

Info

Publication number
SG11201700530PA
SG11201700530PA SG11201700530PA SG11201700530PA SG11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA SG 11201700530P A SG11201700530P A SG 11201700530PA
Authority
SG
Singapore
Prior art keywords
agent
preventing
cognitive impairment
brain function
treating cognitive
Prior art date
Application number
SG11201700530PA
Inventor
Hiroshi Kunugi
Miho Ota
Junko Matsuo
Yoshitatsu Ichihara
Original Assignee
Food Science Inst Foundation
Nat Ct Neurology & Psychiatry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Food Science Inst Foundation, Nat Ct Neurology & Psychiatry filed Critical Food Science Inst Foundation
Publication of SG11201700530PA publication Critical patent/SG11201700530PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1722—Plasma globulins, lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/194—Triglycerides
    • A23V2250/1944—Medium-chain triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG11201700530PA 2014-07-23 2015-07-23 Agent for improving brain function and agent for preventing or treating cognitive impairment SG11201700530PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014149990 2014-07-23
PCT/JP2015/070976 WO2016013617A1 (en) 2014-07-23 2015-07-23 Brain function improving agent, and prophylactic or therapeutic agent for cognitive dysfunction

Publications (1)

Publication Number Publication Date
SG11201700530PA true SG11201700530PA (en) 2017-02-27

Family

ID=55163141

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201700530PA SG11201700530PA (en) 2014-07-23 2015-07-23 Agent for improving brain function and agent for preventing or treating cognitive impairment

Country Status (8)

Country Link
US (2) US20180169052A1 (en)
EP (1) EP3173089B1 (en)
JP (1) JP6609555B2 (en)
CN (1) CN106535919A (en)
CA (1) CA2955915A1 (en)
SG (1) SG11201700530PA (en)
TW (1) TWI722992B (en)
WO (1) WO2016013617A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6935994B2 (en) * 2016-08-19 2021-09-15 株式会社明治 Composition for promoting ketone body production
JP2018184369A (en) * 2017-04-26 2018-11-22 株式会社明治 Intellectual work ability improvement composition and cognition ability improvement composition
JP7157743B2 (en) * 2017-07-26 2022-10-20 株式会社明治 Ketone body production accelerator
CA3093703A1 (en) * 2018-03-15 2019-09-19 Cerecin Inc. Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
AU2019300084A1 (en) * 2018-07-10 2020-11-26 Société des Produits Nestlé S.A. MCT formulations for increasing ketone exposure and methods of making and using such formulations
JP7011984B2 (en) * 2018-07-13 2022-01-27 キリンホールディングス株式会社 Composition for improving attention function and judgment function
CN111096455A (en) * 2020-01-15 2020-05-05 浙江科技学院 Total nutrient formula food for resisting senile dementia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3486778B2 (en) * 1993-04-02 2004-01-13 三菱ウェルファーマ株式会社 Alzheimer's disease preventive / treatment agent
EP1090636A1 (en) * 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
CN101405054B (en) * 2005-12-15 2013-07-17 雀巢技术公司 Compositions and methods for preserving brain function
HUE040002T2 (en) * 2006-04-03 2019-02-28 Accera Inc Use of ketogenic compounds for treatment of age-associated memory impairment
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
SI2528456T1 (en) * 2010-01-29 2014-07-31 N.V. Nutiricia Liquid enteral nutritional composition suitable for tube feeding
WO2014027022A1 (en) * 2012-08-14 2014-02-20 Nestec S.A. Dietetic compositions for the treatment of malnutrition, neurological diseases and metabolic diseases

Also Published As

Publication number Publication date
EP3173089A1 (en) 2017-05-31
EP3173089C0 (en) 2023-10-25
EP3173089B1 (en) 2023-10-25
JPWO2016013617A1 (en) 2017-05-25
CN106535919A (en) 2017-03-22
TWI722992B (en) 2021-04-01
WO2016013617A1 (en) 2016-01-28
US20180169052A1 (en) 2018-06-21
JP6609555B2 (en) 2019-11-20
EP3173089A4 (en) 2018-04-04
TW201613632A (en) 2016-04-16
CA2955915A1 (en) 2016-01-28
US20200108040A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
IL262225A (en) Methods for monitoring and treating cancer
IL278018A (en) Methods for treating or preventing ophthalmological conditions
ZA201705673B (en) Methods for treating skin
HUE063858T2 (en) Brain function improving agent
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
SG11201700530PA (en) Agent for improving brain function and agent for preventing or treating cognitive impairment
IL262223A (en) Methods for monitoring and treating cancer
HK1261918A1 (en) Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
IL262825A (en) Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions
HK1254362A1 (en) Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
IL250213B (en) Method for treating radiotherapy-and-chemotherapy associated cognitive or emotional impairment with cannabinoids
HK1244211A1 (en) Method for treating, preventing, or reducing the risk of skin infection
HK1211441A1 (en) Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
IL255012A0 (en) Compositopns and methods for treating skin conditions
GB201617715D0 (en) Methods for the treatment and prevention of ebola
GB201617591D0 (en) Methods for the treatment and prevention of ebola
GB201617590D0 (en) Methods for the treatment and prevention of ebola
SG11201804140PA (en) Acidic-gas treating agent and acidic-gas treating method
GB201518489D0 (en) Methods for the treatment and prevention of ebola
GB201415876D0 (en) Methods for the treatment and prevention of Ebola